Focused Pilot Award – HT942526PCARPFPTA
- Letters of Intent due 16 September 2026
- Up to USD$300,000 over 2 years
- Supports the exploration and development of impactful and innovative concepts under a patient-centred focus are that could ultimately lead to major advancements that will have a profound effect on patients’ overall quality of life.
- Must address the supportive care, quality of life and survivorship research focus area
- Preliminary data not required
- Pre-clinical animal studies and clinical trials not allowed
- Apply here
- Document – Program Announcement – HT942526PCARPFPTA_GG
Idea Development Award – HT942526PCARPIDA
- Pre-proposals due 7 July 2026
- Up to USD$700,000 over 3 years (Single PI)
- Supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with pancreatic cancer.
- Must address at least one of the focus areas
- Preliminary data required
- Clinical trials not allowed
- Apply here
- Document – Program Announcement – HT942526PCARPIDA_GG
Idea Development Award – Partnering PI Option for Early Career Investigator –HT942526PCARPIDA
- Pre-proposals due 7 July 2026
- Up to USD$950,000 over 3 years
- supports applications that propose to partner an experienced PI (Initiating Partner – Mentor) with an early-career investigator who wishes to pursue a career in pancreatic cancer research.
- Early Career Investigator must be within 8 years of their first faculty appointment (instructor or above) or equivalent
- Supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with pancreatic cancer.
- Must address at least one of the focus areas
- Preliminary data required
- Clinical trials not allowed
- Apply here
- Document – Program Announcement – HT942526PCARPIDA_GG
Translational Research Partnership Award – HT942526PCARPTRPA
- Pre-proposals due 7 July 2026
- Up to USD$1.1M over 3 years
- Supports partnerships between clinicians, population scientists, applied scientists and/or basic scientists that accelerate the movement of promising ideas in pancreatic cancer toward clinical applications.
- At least one member of the partnership must demonstrate expertise either in pancreatic cancer research or pancreatic cancer patient care. At least one member of the partnership must demonstrate expertise either in pancreatic cancer research or pancreatic cancer patient care.
- Must address at least one of the Focus Areas
- Preliminary data required
- Retrospective tissue analysis, correlative studies and small pilot clinical trials allowed.
- Apply here
- Document – Program Announcement – HT942526PCARPTRPA_GG
Focus Areas
- Early detection research
- Identification and characterization of risk
- Supportive care, quality of life and survivorship research
- Understanding metabolic disruptions and their systemic effects, including diabetes and cachexia
- Understanding tumour development from precursors to metastasis
- Biomarkers to predict therapeutic response and guide management strategies
- New therapeutic targets and approaches
